We recently published a list of These 10 Firms Took A Hit on Friday. In this article, we are going to take a look at where ...

Novo Nordisk's long-acting insulin Tresiba is set to gain new ... where biosimilars are driving down prices of Sanofi’s drug. Tresiba was approved by the FDA in 2015 on the basis of top-line ...

Crucially, the long-acting insulin was no worse than Tresiba when it came to rates of ... versus 0.27 events for the once-daily drug. Novo Nordisk said that if approved for use, insulin icodec ...

In a bid to bring down the cost of insulin, California under Gov. Gavin Newsom inked a contract to produce the drug. It's ...

A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...

Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind the schedule he announced and unlikely to make it to market for ...

Columbus joined a slough of cities, states and counties in suing drug companies and pharmacy benefit managers who they say artificially raised insulin prices for decades and profited from it ...

Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a rise in generic options. Insulin prices averaged 19 cents per unit as ...